A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- JUNGYUN LEE, Ph.D.
Severance Hospital, Yonsei University Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Monash Medical Centre
Clayton, Clayton Rd., Australia
Active, not recruiting - Calvary Mater Newcastle
Waratah, Edith Saint, Australia
Active, not recruiting - Peter Maccallum Cancer Centre
Melbourne, Grattan Saint, Australia
Active, not recruiting
- University of Hong Kong
Hong Kong, Pok Fu Ram, Hong Kong
Active, not recruiting
- Kurume University Hospital
Kurume, Fukuoka, Japan
Recruiting - Fukushima Medical University Hospital
Fukushima, Fukushima, Japan
Recruiting - Mie University Hospital
Tsu, Mie-ken, Japan
Recruiting - Tohoku University Hospital
Sendai, Miyagi, Japan
Recruiting - Niigata Cancer Center Hospital
Niigata, Niigata, Japan
Recruiting - Saitama Medical University International Medical Center
Hidaka, Saitama, Japan
Kosei Hasegawa, Ph.DRecruiting - Tokushima University Hospital
Tokushima, Tokushima, Japan
Recruiting - the Cancer Institute Hospital of Jfcr
Tokyo, Tokyo, Japan
Recruiting - the Jikei University Hospital
Tokyo, Tokyo, Japan
Recruiting - University of Tsukuba Hospital
Tsukuba, ㅊ Ibaraki, Japan
Recruiting
- National University Hospital
Singapore, Kent Ridge Rd, Singapore
Active, not recruiting - National University Hospital
Singapore, Singapore
Not, yet, recruiting
- Severance Hospital, Yonsei Health System
Seoul, Seoul, South Korea
Recruiting - National Cancer Center
Goyang-si, South Korea
Recruiting - Bundang Seoul National University Hospital
Seongnam-si, South Korea
Recruiting - Asan Medical Center
Seoul, South Korea
Recruiting - Korea University Guro Hospital
Seoul, South Korea
Recruiting - Samsung Medical Center
Seoul, South Korea
Recruiting - Seoul National University
Seoul, South Korea
Recruiting
- Taipei Veterans General Hospital
Taipei, Beitou District, Taiwan
Active, not recruiting - Chang Gung Memorial Hospital
Taipei, Songshan District, Taiwan
Active, not recruiting - National Taiwan University Hospital
Taipei, Zhongzheng, Taiwan
Active, not recruiting
- Guy'S and St Thomas' Nhs Foundation Trust
London, Monkton, United Kingdom
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jan 2024
- Primary completion
- 31 Aug 2027
- Completion
- 31 Dec 2029
- Last update posted
- 6 May 2026
- Registered enrollment
- 198
- Registry id
- NCT06023862
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.